4 Top Value Stocks to Buy Now as Wall Street Takes Fresh Notice
Four low P/CF value picks, Nexa Resources, Avnet, Strategic Education and USANA Health, screened for discount valuations and strong trading volume.
USNA - USANA Health Sciences, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$35.00
DETAILS
HIGH:
$35.00
LOW:
$35.00
MEDIAN:
$35.00
CONSENSUS:
$35.00
UPSIDE:
86.77%
Stock News
USNA or SDZNY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks presents investors with the better value opportunity right now?
USANA Health (USNA) Upgraded to Buy: What Does It Mean for the Stock?
USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
USANA's People-First Culture Earns Spot on USA TODAY Top Workplaces List
SALT LAKE CITY, May 7, 2026 /PRNewswire/ -- USANA Health Sciences (NYSE: USNA), a global leader in cellular nutrition, is proud to announce it has earned a spot on the prestigious 2026 USA TODAY Top Workplaces award list. The award honors organizations with 150 or more employees that have created exceptional, people-first cultures.
USANA Health Sciences, Inc. (USNA) Q1 2026 Earnings Call Transcript
USANA Health Sciences, Inc. (USNA) Q1 2026 Earnings Call Transcript
USANA Health Sciences (USNA) Q1 Earnings and Revenues Surpass Estimates
USANA Health Sciences (USNA) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.73 per share a year ago.
USANA Health Sciences Reports First Quarter 2026 Results
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended April 4, 2026. Key Financial Results First Quarter 2026 vs. First Quarter 2025 Net sales of $250 million versus $250 million. Net earnings of $7.5 million versus $9.4 million. Diluted EPS of $0.41 as compared with $0.49. Adjusted diluted EPS(1) of $0.61 as compared with $0.73. Adjusted EBITDA(2) of $28.4 million versus $29.8 million. Core Nutritional Act.
During National Show Your Smile Month, Kevin Guest Urges Leaders to Lift Others Daily
SALT LAKE CITY, May 1, 2026 /PRNewswire/ -- During May's National Show Your Smile Month, Kevin Guest, Chairman and CEO of USANA Health Sciences (NYSE: USNA), is calling on leaders to use one of the most overlooked tools in business and life: a genuine smile. "Smiling isn't surface-level," said Kevin Guest.
One Capsule, Endless Glow--Radiant Skin Starts Within
Introducing Glow ™ , USANA's first skin supplement SALT LAKE CITY, April 27, 2026 /PRNewswire/ -- USANA Health Sciences (NYSE: USNA), a global leader in cellular nutrition, proudly announces the launch of Glow, an innovative skincare supplement designed to support radiant, even-toned skin from within.* Glow represents a new frontier for USANA—moving beyond topical solutions to address skin health at the cellular level.
Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
USANA Schedules First Quarter 2026 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2026 results will be released after the close of market on Tuesday, May 5, 2026. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and instituti.
USNA vs. SDZNY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks is more attractive to value investors?
USANA CEO Kevin Guest Calls for Daily Health Routines on World Health Day
SALT LAKE CITY, April 1, 2026 /PRNewswire/ -- For World Health Day April 7, Kevin Guest, Chairman and CEO of USANA Health Sciences (NYSE: USNA), is calling for a shift away from awareness only and toward execution to improve health. "Most people know how to improve their health; they just don't do it consistently," said Guest.
Tested, Trusted, Approved: USANA CellSentials Earns ConsumerLab.com Seal of Approval for Purity and Potency
SALT LAKE CITY, March 24, 2026 /PRNewswire/ -- USANA (NYSE: USNA), a global leader in cellular nutrition, today announced that its flagship CellSentials supplement has earned the prestigious ConsumerLab.com Seal of Approval. This highly respected third-party certification is awarded only to products that meet rigorous standards for purity, potency, and label accuracy.
USNA or ZTS: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck right now?
USANA Health (USNA) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
USANA Health (USNA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
5 Low P/B Ratio Stocks That You May Consider Buying in March
Ford, USANA, Strategic Education, Patria Investments and Concentrix are some low P/B picks, signaling potential undervaluation and growth prospects.
USANA Health (USNA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
USANA Health (USNA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
4 Value Stocks to Buy as Middle East Tensions Keep Markets on Edge
Value plays STRA, USNA, ARW and USB screen cheap on price-to-cash-flow as Middle East tensions and tariff worries keep markets volatile.
Price Targets
USANA Health Sciences Inc. (USNA) PT Lowered to $35 at DA Davidson
$35.00
(was $34.48)
Linda Bolton Weiser
·
D.A. Davidson
Usana price target lowered to $38 from $46 at DA Davidson
$38.00
(was $42.97)
Linda Bolton Weiser
·
D.A. Davidson
USANA Health Sciences Inc. (USNA) PT Lowered to $46 at DA Davidson
$46.00
(was $44.79)
Linda Bolton Weiser
·
D.A. Davidson
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $76
$76.00
(was $75.52)
D.A. Davidson